PRESS RELEASE published on 08/04/2025 at 07:00, 7 months 23 days ago Informations privilégiées / Autres communiqués Innate Pharma publie son nouveau nombre d'actions et de droits de vote au 1er août 2025 selon les réglementations de l'AMF. Détails ci-dessous Nombre D'actions Droits De Vote AMF Innate Pharma Biotechnologies
BRIEF published on 07/04/2025 at 07:05, 8 months 23 days ago Innate Pharma annonce une mise à jour de ses actions et de ses droits de vote Euronext Actions Nasdaq Droit De Vote Innate Pharma
BRIEF published on 07/04/2025 at 07:05, 8 months 23 days ago Innate Pharma Announces Share and Voting Rights Update Voting Rights Shares Euronext Nasdaq Innate Pharma
PRESS RELEASE published on 07/04/2025 at 07:00, 8 months 23 days ago Inside Information / Other news releases Innate Pharma discloses number of shares and voting rights as of July 3, 2025, in accordance with French regulations. Total shares: 92,183,523. Total voting rights: 92,962,943 (theoretical) and 92,944,368 (exercisable) Voting Rights Shares French Regulations Financial Disclosure Innate Pharma
BRIEF published on 06/17/2025 at 07:05, 9 months 10 days ago Innate Pharma participera à des conférences d'investisseurs clés Biotechnologie Immunothérapie Soins De Santé Conférences D'investisseurs Innate Pharma
BRIEF published on 06/17/2025 at 07:05, 9 months 10 days ago Innate Pharma to Participate in Key Investor Conferences Biotechnology Investor Conferences Healthcare Immunotherapy Innate Pharma
PRESS RELEASE published on 06/17/2025 at 07:00, 9 months 10 days ago Inside Information / Other news releases Innate Pharma to participate in H.C. Wainwright and Wolfe Research healthcare conferences showcasing their innovative immunotherapy approaches. Global biotech company expanding portfolio Biotechnology Immunotherapy Clinical-stage Innate Pharma Healthcare Conferences
BRIEF published on 06/13/2025 at 07:05, 9 months 14 days ago L'IPH6501 d'Innate Pharma montre un potentiel dans le traitement du lymphome Innate Pharma Résultats Précliniques IPH6501 R-CHOP Lymphome
BRIEF published on 06/13/2025 at 07:05, 9 months 14 days ago Innate Pharma's IPH6501 Shows Potential in Lymphoma Treatment Innate Pharma Preclinical Results IPH6501 Lymphoma R-CHOP
PRESS RELEASE published on 06/13/2025 at 07:00, 9 months 14 days ago Inside Information / Other news releases Innate Pharma highlights preclinical antitumor activity of IPH6501 in DLBCL and FL at the 2025 EHA Congress, presenting potent efficacy in in vitro and in vivo models with R-CHOP combination Preclinical Data EHA Congress Innate Pharma Antitumor Activity IPH6501
Published on 03/27/2026 at 09:30, 1 hour 10 minutes ago Amap Street Stars Launches Macao Authentic Delicacies Ranking to Drive Cultural-Tourism Innovation in the Greater Bay Area
Published on 03/27/2026 at 08:05, 2 hours 35 minutes ago Battery X Metals Announces Corporate Awareness Engagements
Published on 03/26/2026 at 23:00, 11 hours 40 minutes ago FutureGen Industries Announces Closing of Debt Settlement
Published on 03/26/2026 at 22:05, 12 hours 35 minutes ago BlackBerry to Announce Fourth Quarter and Fiscal Year 2026 Results on April 9, 2026
Published on 03/26/2026 at 22:00, 12 hours 40 minutes ago Clean Air Metals Receives Provincial Funding and Provides Update on the Thunder Bay North Project
Published on 03/27/2026 at 10:23, 17 minutes ago Original-Research: HORNBACH Holding AG & Co. KGaA (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 03/27/2026 at 10:00, 40 minutes ago AlphaPet Ventures welcomes Cpro Food, one of the leading super-premium brands for dog and cat food in Belgium
Published on 03/27/2026 at 09:45, 55 minutes ago DESTINUS Named to Fast Company's Annual List of the World's Most Innovative Companies of 2026
Published on 03/27/2026 at 09:39, 1 hour ago Grünenthal achieves outstanding financial results in 2025, powered by strategic growth, integration and diversification
Published on 03/27/2026 at 09:37, 1 hour 3 minutes ago MEDICLIN lays a solid foundation for further growth with its 2025 financial results
Published on 03/27/2026 at 07:00, 3 hours 40 minutes ago WEB SA - CONVOCATION ASSEMBLEE GENERALE ORDINAIRE EXERCICE 2025 - 28/04/2026
Published on 03/26/2026 at 18:17, 16 hours 23 minutes ago Eiffage se renforce au capital de Getlink et porte sa participation à 29,40 % du capital
Published on 03/26/2026 at 18:17, 16 hours 23 minutes ago Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 18:00, 16 hours 40 minutes ago Arrêté des comptes au 31 décembre 2025 et perspectives 2026
